Cytokinetics Stock Forecast for 2023 - 2025 - 2030
Updated on 05/31/2023
Cytokinetics Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for Cytokinetics, with the average target coming in at $60.00. If it were to be achieved, this would result in a potential upside of approximately 58.06 percent from the most recent closing price in May, 2023. The high end is $80.00, and the low is $55.00. If you're interested in CYTK stock, it's important to compare it to other companies in the industry.
58.06% Upside
Cytokinetics Fair Value Forecast for 2023 - 2025 - 2030
Cytokinetics's Price has seen growth In the last two years, going from $0.00 to $0.00 – a gain of 100.00% In the next year, analysts believe that Fair Value will reach $40.44 – an increase of 100.00%. For the next eight years, the forecast is forFair Value to grow by 100.00%.
Cytokinetics Revenue Forecast for 2023 - 2025 - 2030
Cytokinetics's Revenue has seen growth In the last two years, going from $26.87M to $70.43M – a gain of 162.11% According to 14 prominent analysts, Cytokinetics's Revenue will fall by 39.73% in the next year, reaching $42.45M. For the next eight years, the forecast is forRevenue to grow by 3378.26%.
.jpg)
Cytokinetics Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last two years, Cytokinetics's Free Cash Flow has increased by 104.63%, going from $-93.53M to $-191.39M. In the next year, analysts are expecting an increase in Free Cash Flow, predicting it will reach $-334.00M – an increase of 74.51%. According to professional forecasts, in 2030, Cytokinetics's Free Cash Flow will decrease by 953.75%, reaching $1.63B.
Cytokinetics Net Income Forecast for 2023 - 2025 - 2030
Cytokinetics's Net Income has grown in the last two years, jumping from $-121.69M to $-215.31M – an increase of 76.93%. In the next year, analysts predict that Net Income will reach $-420.57M – an increase of 95.33%. Professionals believe that By 2030, Cytokinetics's Net Income will fall to $1.29B– a 700.52% decrease from its current value.
Cytokinetics EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Cytokinetics's EBITDA has grown, increasing from $-97.57M to $-184.04M – an increase of 88.62%. For next year, the 4 analysts predict EBITDA of $-457.86M, which would mean an increase of 148.78%. Professionals believe that By 2030, Cytokinetics's EBITDA will fall to $742.24M – a 503.30% decrease from its current value.
Cytokinetics EBIT Forecast for 2023 - 2025 - 2030
Cytokinetics's EBIT has increased by 88.44% In the last two years, going from $-98.87M to $-186.31M. In the next year, analysts expect EBIT to reach $-428.69M – an increase of 130.10%. In 2030, professionals predict that Cytokinetics's EBIT will decrease by 800.93%, to $1.31B.
Cytokinetics EPS Price Prediction Forecast for 2023 - 2025 - 2030
Cytokinetics's EPS has seen growth In the last two years, going from $-2.11 to $-2.80 – a gain of 32.70% In the next year, analysts believe that EPS will reach $-4.70 – an increase of 67.86%. By 2030, professionals believe that Cytokinetics's EPS will decrease by 322.14%, reaching $6.22 – a concerning trend for the company.
.jpg)